SciSparc:Neurothera Labs与Clearmind Medicine合作申请以色列专利,开发新型非致幻神经塑造剂用于抑郁症治疗

美股速递
Nov 20, 2025

SciSparc:Neurothera Labs与Clearmind Medicine合作申请以色列专利,开发新型非致幻神经塑造剂用于抑郁症治疗

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10